Biogen, Inc. (BIIB)
189.69
+1.89
(+1.01%)
USD |
NASDAQ |
May 21, 16:00
185.79
-3.90
(-2.06%)
After-Hours: 19:59
Biogen Accounts Payable (Quarterly) : 358.50M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Amgen, Inc. | 2.935B |
| Gilead Sciences, Inc. | 645.00M |
| AbbVie, Inc. | 33.61B |
| Apellis Pharmaceuticals, Inc. | 49.05M |
| Moderna, Inc. | 161.00M |